Topotecan in mantle cell lymphoma - A 21 day continuous infusion regimen may have advantages over intermittent therapy.

Antzeko izenburuak

• Weekly topotecan regimen in the treatment of recurrent ovarian cancer: search for alternatives to upholding the quality of life
  nork: E. G. Novikova, et al.
  Argitaratua: (2014-08-01)
• Repeated Infusions of Brexucabtagene-autoleucel in Relapsed/Refractory Mantle Cell Lymphoma
  nork: Enver Aydilek, et al.
  Argitaratua: (2023-09-01)
• The role of topotecan in cancer ginecology treatment
  nork: A. G. Kedrova, et al.
  Argitaratua: (2017-02-01)
• Recurrent ovarian cancer: prolongation of the platinum-free interval with the use of a weekly treatment regimen of hycamtin (topotecan)
  nork: E. G. Novikova, et al.
  Argitaratua: (2014-07-01)
• The leadership of topotecan in the treatment of recurrent platinum-resistant ovarian cancer
  nork: K. E. Borisov
  Argitaratua: (2014-07-01)